Correlation Engine 2.0
Clear Search sequence regions


  • CHD7 (1)
  • child (1)
  • cohort (2)
  • embryogenesis (1)
  • factors (2)
  • female (1)
  • FGF17 (1)
  • HESX1 (1)
  • humans (1)
  • IGSF10 (3)
  • immunoglobulins (2)
  • LHX3 (1)
  • LHX4 (1)
  • MLPA (1)
  • patients (6)
  • POU1F1 (1)
  • PROP1 (4)
  • protein human (2)
  • SEMA3A (5)
  • WDR11 (1)
  • Sizes of these terms reflect their relevance to your search.

    Background: The mutation frequencies of pituitary transcription factors genes in patients with combined pituitary hormone deficiencies (CPHD) vary substantially between populations. However, apart from PROP1 the mutation rate of other genes is low and for almost half of the patients with CPHD the routine sequencing of known genes is unsuccessful in the identification of genetic causes. Methods: A cohort of 66 sporadic and nine familial CPHD cases (80 patients in total) were subjected to initial testing of the genes PROP1, POU1F1, LHX3, LHX4, and HESX1 using a targeted gene panel and MLPA. In patients who tested negative, a whole exome sequencing approach was employed. Results: In nine of the familial cases and 32 of the sporadic patients mutations in the PROP1 gene were found (the common pathogenic variants included c.301_302delAG and c.150delA). Mutations were also found in genes so far not related directly to CPHD. A unique homozygous and clinically relevant variant was identified in the SEMA3A gene, which may contribute to neural development and his phenotypic spectrum including short stature and isolated hypogonadotropic hypogonadism (IHH). Another pathogenic variant p.A1672T was found in the IGSF10 gene reported to be responsible for delayed puberty and neuronal migration during embryogenesis. Several suspected novel but predicted benign variants were also identified for the CHD7, WDR11 and FGF17 genes. Conclusion: Although PROP1 defects account for a majority of CPHD patients, identification of rare, less frequent variants constitutes a big challenge. Multiple genetic factors responsible for CPHD are still awaiting discovery and therefore the usage of efficient genomic tools (i.e., whole exome sequencing) will further broaden our knowledge regarding pituitary development and function. Copyright © 2020 Budny, Zemojtel, Kaluzna, Gut, Niedziela, Obara-Moszynska, Rabska-Pietrzak, Karmelita-Katulska, Stajgis, Ambroziak, Bednarczuk, Wrotkowska, Bukowska-Olech, Jamsheer, Ruchala and Ziemnicka.

    Citation

    Bartlomiej Budny, Tomasz Zemojtel, Malgorzata Kaluzna, Pawel Gut, Marek Niedziela, Monika Obara-Moszynska, Barbara Rabska-Pietrzak, Katarzyna Karmelita-Katulska, Marek Stajgis, Urszula Ambroziak, Tomasz Bednarczuk, Elzbieta Wrotkowska, Ewelina Bukowska-Olech, Aleksander Jamsheer, Marek Ruchala, Katarzyna Ziemnicka. SEMA3A and IGSF10 Are Novel Contributors to Combined Pituitary Hormone Deficiency (CPHD). Frontiers in endocrinology. 2020;11:368

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32612575

    View Full Text